Sterling Capital Management LLC Celldex Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 98 shares of CLDX stock, worth $2,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98Holding current value
$2,630% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
205Shares Held
67.2MCall Options Held
1.55MPut Options Held
736K-
Wellington Management Group LLP Boston, MA9.24MShares$248 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$104 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$92.8 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$89.4 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.26B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...